Claritev Corporation (CTEV) Earnings Call Transcripts

50 earnings calls from August 2020 to May 14, 2026

NYSE US Health Care Health Care Technology

Claritev Corporation's Latest Earnings Call - May 14, 2026

In Q1 2026, Claritev Corporation (CTEV:US) reported a revenue of $250 million, reflecting an 8.4% year-over-year increase, and earnings per share (EPS) of $0.45, which was inline with expectations. Management maintained its long-term revenue guidance of at least $1.1 billion by 2028 and $1.3 billion by 2030, indicating a strong growth trajectory. Notably, the company highlighted a significant increase in bookings, reaching $44.1 million in Q1, which is a critical indicator of future revenue growth and market penetration.

Reported metrics

MetricValueContext
Revenue $250 million (beat) vs $230 million est, +8.4% YoY
EPS $0.45 (inline) inline with expectations
Bookings $44.1 million (beat) vs $23.1 million last quarter
Claims Intelligence Growth 8.4% (positive) year-over-year growth
Long-term Revenue Guidance At least $1.1 billion by 2028 (neutral) maintained guidance
ACV from World Trade Center Contract $5 million (positive) new public sector opportunity

Guidance from management

Management maintained its long-term revenue targets of at least $1.1 billion by 2028 and $1.3 billion by 2030, indicating confidence in growth and profitability.

What management said

Yes. I think it's probably early to tell. So as we're kind of finalizing our provider strategy, which we'll share it at some point in the future, the public sector opportunities from my past life, if you won one big deal and it was like a multibillion-dollar deal. And so I think in large, I wouldn't be surprised if they were ratable I think, longer term, a stable recurring revenue provider business is a really great ...
— Doug Garis, May 14, 2026 earnings call
Yes, absolutely. And I think the big psychological change for us, maybe relating back to the puts and takes, we are a product and technology organization, and we have a published road map. So now I can go on a quarterly basis, I can go to my customers and say, "Hey, do you know in Q3 of '26, I'm releasing this thing for NSA and we should be planning for it". So when you think about activating a sales motion, building...
— Doug Garis, May 14, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the sustainability of growth in the public sector and the competitive landscape regarding AI integration. There were questions about how Claritev plans to maintain its market position amidst increasing competition and technological advancements.

Main topics on the call

Read the full Claritev Corporation transcript (May 14, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Claritev Corporation

Claritev Corporation (CTEV) is a publicly listed company in the Health Care Technology industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 50 calls on record spanning August 18, 2020 to May 14, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 50 Claritev Corporation earnings call transcripts on record, spanning August 18, 2020 to May 14, 2026. Based on this history, Claritev Corporation reports quarterly. The most recent call on file is dated May 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
CTEV
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Health Care Technology
Calls on record
50
First call
August 18, 2020
Most recent
May 14, 2026
Reporting cadence
quarterly
Quarter Date
Company Conference Presentations May 14, 2026 Read transcript
Q1 FY2026 May 7, 2026 Read transcript
Analyst/Investor Day Mar 16, 2026 Read transcript
Special Calls Mar 6, 2026 Read transcript
Q4 FY2025 Feb 23, 2026 Read transcript
Company Conference Presentations Jan 15, 2026 Read transcript
Company Conference Presentations Dec 2, 2025 Read transcript
Q3 FY2025 Nov 7, 2025 Read transcript
Company Conference Presentations Sep 9, 2025 Read transcript
Q2 FY2025 Aug 6, 2025 Read transcript
Q1 FY2025 May 8, 2025 Read transcript
Q4 FY2024 Feb 25, 2025 Read transcript
Q3 FY2024 Nov 5, 2024 Read transcript
Q2 FY2024 Aug 1, 2024 Read transcript
Company Conference Presentations May 15, 2024 Read transcript
Q1 FY2024 May 8, 2024 Read transcript
Company Conference Presentations Mar 12, 2024 Read transcript
Q4 FY2023 Feb 29, 2024 Read transcript
Company Conference Presentations Jan 9, 2024 Read transcript
Company Conference Presentations Nov 28, 2023 Read transcript
Q3 FY2023 Nov 7, 2023 Read transcript
Company Conference Presentations Oct 3, 2023 Read transcript
Company Conference Presentations Sep 11, 2023 Read transcript
Q2 FY2023 Aug 2, 2023 Read transcript
Analyst/Investor Day Jun 28, 2023 Read transcript
Q1 FY2023 May 4, 2023 Read transcript
Company Conference Presentations Mar 14, 2023 Read transcript
Company Conference Presentations Mar 2, 2023 Read transcript
Q4 FY2022 Feb 28, 2023 Read transcript
Company Conference Presentations Nov 29, 2022 Read transcript
Q3 FY2022 Nov 8, 2022 Read transcript
Company Conference Presentations Sep 13, 2022 Read transcript
Q2 FY2022 Aug 4, 2022 Read transcript
Company Conference Presentations May 12, 2022 Read transcript
Q1 FY2022 May 10, 2022 Read transcript
Shareholder/Analyst Calls Apr 26, 2022 Read transcript
Company Conference Presentations Mar 16, 2022 Read transcript
Company Conference Presentations Feb 23, 2022 Read transcript
Q4 FY2021 Feb 17, 2022 Read transcript
Company Conference Presentations Dec 1, 2021 Read transcript
Company Conference Presentations Nov 11, 2021 Read transcript
Special Calls Nov 8, 2021 Read transcript
Q3 FY2021 Nov 3, 2021 Read transcript
Q2 FY2021 Aug 5, 2021 Read transcript
Shareholder/Analyst Calls May 27, 2021 Read transcript
Q1 FY2021 May 13, 2021 Read transcript
Q4 FY2020 Mar 10, 2021 Read transcript
Q3 FY2020 Nov 12, 2020 Read transcript
Q2 FY2020 Aug 18, 2020 Read transcript
Analyst/Investor Day Aug 18, 2020 Read transcript